BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3669506)

  • 1. [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
    Behrens-Baumann W; Uter W; Ansorg R
    Klin Monbl Augenheilkd; 1987 Aug; 191(2):125-8. PubMed ID: 3669506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
    Behrens-Baumann W; Klinge B
    Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of corticosteroids in antimycotic therapy of Candida keratitis].
    Behrens-Baumann W; Küster M
    Klin Monbl Augenheilkd; 1987 Sep; 191(3):222-5. PubMed ID: 3682686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical fluconazole for experimental candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Rüchel R
    Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].
    Pleyer U; Grammer J; Pleyer JH; Kosmidis P; Friess D; Schmidt KH; Thiel HJ
    Ophthalmologe; 1995 Aug; 92(4):469-75. PubMed ID: 7549331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal experiment model of keratomycosis].
    Behrens-Baumann W; Uter W; Vogel M; Ansorg R
    Klin Monbl Augenheilkd; 1987 Jun; 190(6):496-500. PubMed ID: 3626408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Keratomycosis caused by Candida albicans].
    Arocker-Mettinger E; Huber-Spitzy V; Haddad R; Grabner G
    Klin Monbl Augenheilkd; 1988 Aug; 193(2):192-4. PubMed ID: 3263535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):874-80. PubMed ID: 3553060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
    Pleyer U; Legmann A; Mondino BJ; Lee DA
    Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
    Chen N; Yang YT; Dong XG; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1984; 22(4):323-30. PubMed ID: 6095470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis.
    Stern GA; Okumoto M; Smolin G
    Arch Ophthalmol; 1979 Apr; 97(4):721-2. PubMed ID: 426691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
    Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
    Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits.
    Liu KR; Peyman GA; Khoobehi B
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1527-34. PubMed ID: 2787300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Uter W
    Mycoses; 1990; 33(11-12):567-73. PubMed ID: 2103595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.